Delivery Order SPE2DB20D3103-SPE2DB25FQ3G3
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,478.27. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,755.26. This competitively awarded, non-set-aside delivery order carries a firm fixed price structure with an ultimate completion date of September 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 36 mg tablets (100-count) on August 28, 2025, with a ceiling value of $1,825.53. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles) with a ceiling value of $1,028.46. This competitively awarded, firm fixed-price delivery order is scheduled for completion by April 25, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was open to all...
- The Defense Logistics Agency awarded a delivery order valued at $1,690.77 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on July 30, 2025, with completion scheduled for July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order falls under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,612.72 to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count supply) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded contract under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a $1,978.18 delivery order by the Defense Logistics Agency (DLA) on September 16, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count bottles). This firm fixed-price, competitively awarded contract is scheduled for completion by September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a child delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a firm fixed price ceiling value of $1,810.72. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Methylphenidate ER (extended-release) tablets at 54mg dosage. This firm fixed-price delivery order, valued at $6,673.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3G3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a ceiling value of $1,440.74. This competitive, non-set-aside award is structured as a firm fixed-price delivery order and is scheduled for completion by September 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's DLA Troop Support Medical contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products and medical supplies across multiple therapeutic domains. Through this prime contract vehicle, AmerisourceBergen supplies medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order for Methylphenidate ER represents one of numerous small-value pharmaceutical transactions fulfilled under this expansive IDC arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/16/25 |